9 Secondary Glaucomas

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/205

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 2:59 AM on 8/5/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

206 Terms

1
New cards

What defines a secondary glaucoma, and how is it related to POAG?

Secondary glaucomas produce the characteristic optic neuropathy seen in POAG, but the elevated IOP is due to an identifiable secondary cause rather than typical POAG or PACG mechanisms.

2
New cards

What are the major categories of causes of secondary glaucoma?

Secondary glaucoma can result from:

  • Another acquired ocular condition

  • An acquired systemic condition

  • Medication use

  • Trauma

3
New cards

What is the key mechanism shared by secondary glaucomas?

Secondary glaucomas involve increased IOP through mechanisms outside of typical POAG or PACG, ultimately causing glaucomatous optic nerve damage.

4
New cards

What are examples of secondary glaucomas caused by ocular syndromes involving material or pigment deposition?

  • Pigmentary glaucoma, secondary to pigment dispersion syndrome

  • Pseudoexfoliation glaucoma, secondary to pseudoexfoliation syndrome

5
New cards

What inflammatory or uveitic conditions can lead to secondary glaucoma?

Inflammatory glaucoma can occur with regular uveitis or special uveitic episodes such as:

  • Glaucomatocyclitic crisis, also called Posner-Schlossman syndrome

  • Fuchs heterochromic iridocyclitis

  • UGH syndrome

6
New cards

What are other major examples of secondary glaucoma?

Other secondary glaucomas include:

  • Steroid-induced glaucoma

  • Traumatic glaucoma

  • Neovascular glaucoma

  • Phacolytic and phacomorphic glaucoma

  • Developmental glaucomas, although these are mostly managed by OMDs and not covered in this lecture

7
New cards

What is the main mechanism of pigmentary dispersion syndrome?

Pigmentary dispersion syndrome involves liberation of pigment granules from the posterior pigmented epithelium on the back surface of the iris.

8
New cards

What is the relationship between pigmentary dispersion syndrome and pigmentary glaucoma?

Pigmentary dispersion syndrome becomes pigmentary glaucoma when optic nerve head damage develops from the pigment-related increase in IOP.

9
New cards

What are the key epidemiologic features of pigmentary dispersion syndrome?

PDS may occur in up to 2.5% of Caucasians, with unclear prevalence in patients of African ancestry. Onset can begin as early as the mid-teens, but diagnosis usually occurs between ages 20 to 40.

10
New cards

How does sex distribution differ between pigmentary dispersion syndrome and pigmentary glaucoma?

PDS has no clear male or female predilection, but more males convert from PDS to pigmentary glaucoma than females.

11
New cards

How does pigmentary dispersion syndrome typically present between the two eyes?

Like other glaucomas, PDS is typically bilateral but asymmetric.

12
New cards

What anterior segment anatomy is commonly associated with pigmentary dispersion syndrome?

Patients with PDS are typically myopic and have a deep anterior chamber.

13
New cards

What is the mechanism causing pigment release in pigmentary dispersion syndrome?

Posterior bowing of the iris causes the iris to rub against the zonules and anterior lens surface during normal iris movement, mechanically liberating pigment from the posterior iris pigment epithelium.

14
New cards

Why does a concave iris configuration increase risk for pigment dispersion?

A concave or posteriorly bowed iris increases contact between the posterior iris and zonules, leading to repeated friction and pigment liberation.

15
New cards

After pigment is liberated in PDS, where does it go and why does that matter clinically?

Liberated pigment enters the aqueous humor and can accumulate in the trabecular meshwork, increasing resistance to aqueous outflow and raising IOP.

16
New cards

What are the two main ways pigment affects the trabecular meshwork in PDS?

Pigment can:

  • Physically block the trabecular meshwork, mechanically resisting aqueous outflow

  • Compromise TM endothelial cells by forcing phagocytosis of pigment granules instead of maintaining active transport/outflow functions

17
New cards

What is the mechanism by which PDS can progress to pigmentary glaucoma?

Posterior iris bowing causes pigment liberation → pigment accumulates in the trabecular meshwork → aqueous outflow resistance increases → IOP rises → optic nerve head damage develops.

18
New cards

What classic iris finding is associated with pigmentary dispersion syndrome?

Radial midperipheral iris transillumination defects caused by loss of pigment from the iris.

<p>Radial midperipheral iris transillumination defects caused by loss of pigment from the iris.</p>
19
New cards

How are iris transillumination defects in PDS best visualized?

They are best seen with retroillumination.

20
New cards

What is important to remember about early iris transillumination defects in PDS?

They can be subtle early in the syndrome, so careful retroillumination is needed to detect the classic radial midperipheral pigment loss.

21
New cards

What is the classic sequence of findings in pigmentary dispersion syndrome?

Myopia/deep anterior chamber → posterior iris bowing → iris-zonule friction → pigment liberation → pigment in aqueous/TM → radial midperipheral iris transillumination defects ± elevated IOP.

22
New cards

What is a Krukenberg spindle in pigmentary dispersion syndrome?

A Krukenberg spindle is vertically oriented pigment accumulation on the posterior corneal endothelium from liberated iris pigment circulating in the aqueous.

<p>A Krukenberg spindle is vertically oriented pigment accumulation on the posterior corneal endothelium from liberated iris pigment circulating in the aqueous.</p>
23
New cards

Besides the corneal endothelium, where else can liberated pigment accumulate in PDS?

Pigment can also accumulate on the iris surface, in addition to the corneal endothelium and trabecular meshwork.

<p>Pigment can also accumulate on the iris surface, in addition to the corneal endothelium and trabecular meshwork.</p>
24
New cards

What anterior segment finding should make you suspect pigment dispersion syndrome on slit lamp exam?

A Krukenberg spindle on the posterior corneal endothelium should raise suspicion for PDS and prompt further evaluation, especially gonioscopy.

<p>A Krukenberg spindle on the posterior corneal endothelium should raise suspicion for PDS and prompt further evaluation, especially gonioscopy.</p>
25
New cards

How does pigment accumulation in the angle contribute to elevated IOP in PDS?

Pigment accumulates in the trabecular meshwork, obstructing aqueous outflow and increasing IOP.

<p>Pigment accumulates in the trabecular meshwork, obstructing aqueous outflow and increasing IOP.</p>
26
New cards

What is Sampolesi’s line?

Sampolesi’s line is extra pigment deposited anterior to Schwalbe’s line.

<p>Sampolesi’s line is extra pigment deposited anterior to Schwalbe’s line. </p>
27
New cards

What exam is necessary when Krukenberg spindle or iris transillumination defects are seen?

Gonioscopy is necessary to evaluate angle pigmentation, trabecular meshwork obstruction, and signs such as Sampolesi’s line.

28
New cards

What is Zentmayer line in pigmentary dispersion syndrome?

Zentmayer line is pigment deposition on the zonules or peripheral anterior lens surface.

<p>Zentmayer line is pigment deposition on the zonules or peripheral anterior lens surface.</p>
29
New cards

Why is Zentmayer line clinically important in PDS?

Zentmayer line is pathognomonic for pigmentary dispersion syndrome.

30
New cards

When can Zentmayer line be seen?

Zentmayer line is only seen during dilation, because the peripheral lens surface and zonules must be visible.

31
New cards

What are the classic pigment deposition signs of PDS and where are they located?

  • Krukenberg spindle: posterior corneal endothelium

  • Sampolesi’s line: anterior to Schwalbe’s line

  • Heavy TM pigment: trabecular meshwork/angle

  • Zentmayer line: zonules or peripheral anterior lens surface

  • Iris transillumination defects: radial midperipheral iris pigment loss

32
New cards

When does pigmentary dispersion syndrome become pigmentary glaucoma?

PDS becomes pigmentary glaucoma when pigment-related IOP elevation causes glaucomatous optic neuropathy.

33
New cards

What percentage of PDS patients are estimated to progress to pigmentary glaucoma?

About 25% of patients with PDS progress to pigmentary glaucoma.

34
New cards

How common is pigmentary glaucoma among all glaucomas?

Pigmentary glaucoma accounts for about 4.4% of all glaucomas.

35
New cards

What can heavy angle pigmentation do during gonioscopy in PDS or pigmentary glaucoma?

Heavy pigment can obscure all angle structures, making gonioscopic assessment more difficult.

36
New cards

Why does the risk of IOP spikes and conversion to pigmentary glaucoma decrease with age in PDS?

Risk decreases due to “burnout”:

  • The iris has less pigment left to release

  • Age-related lens growth pushes the posterior iris away from the zonules

  • Less iris-zonule friction means less pigment liberation

37
New cards

How does lens anatomy affect pigment release in younger versus older PDS patients?

Younger patients have a thinner lens, allowing more posterior iris bowing and iris-zonule friction. Later in life, the thickened lens pushes the iris away from the zonules, reducing friction and pigment release.

38
New cards

What age is clinically important when estimating conversion risk from PDS to pigmentary glaucoma?

Patients with PDS who pass age 45 without significant IOP elevation have a relatively low likelihood of converting to pigmentary glaucoma.

39
New cards

What are the key components of the clinical workup for pigmentary dispersion syndrome?

Workup includes:

  • Corneal evaluation for Krukenberg spindle

  • Iris retroillumination for radial transillumination defects

  • Gonioscopy for heavy TM pigment/Sampolesi’s line

  • IOP measurement to detect spikes

40
New cards

How often should newly diagnosed PDS patients have IOP checked?

Newly diagnosed PDS patients need IOP checks every 3 to 4 months during the first year, then every 6 months thereafter.

41
New cards

Why should young or newly diagnosed PDS patients have IOP checked immediately after vigorous exercise?

Vigorous exercise can cause adrenaline-induced pupillary dilation, which may increase iris-zonule friction and trigger IOP spikes.

42
New cards

What IOP measurement is recommended for all PDS patients after dilation?

All PDS patients should have a post-dilation IOP measurement because dilation can provoke pigment release and IOP elevation.

43
New cards

How is pigmentary glaucoma generally treated initially?

Pigmentary glaucoma is generally treated like POAG, using IOP-lowering medications and escalating therapy as needed.

44
New cards

Which medication class works well for pigmentary glaucoma despite heavy pigment involvement?

Prostaglandin analogs (PGAs) work well in the presence of pigment and are commonly used to lower IOP.

45
New cards

Why can laser trabeculoplasty be effective in pigmentary glaucoma?

ALT and SLT can be effective because pigment in the trabecular meshwork improves laser target absorption, especially in younger patients. Pigment is a predictor of success for ALT.

46
New cards

What is a limitation of laser trabeculoplasty in pigmentary glaucoma compared with POAG?

Laser effects may wear off faster than in POAG. After 3 years, fewer than 50% of pigmentary glaucoma patients continue to show IOP reduction after initial laser therapy.

47
New cards

Why might pilocarpine help young patients with active pigment liberation?

Pilocarpine can reduce pigment liberation by decreasing iris concavity, which reduces iris-zonule friction. It also increases aqueous outflow.

48
New cards

What mechanism makes pilocarpine useful specifically in pigmentary dispersion syndrome?

Pilocarpine causes miosis, which can flatten the posteriorly bowed iris and reduce mechanical rubbing between the iris and zonules.

49
New cards

What ocular side effects limit pilocarpine use in young or pre-presbyopic patients?

Pilocarpine can cause significant side effects, including:

  • Accommodative spasm

  • Miosis

  • Blurred vision

50
New cards

What serious retinal risk is increased with pilocarpine, and why is this especially relevant in PDS?

Pilocarpine increases the risk of retinal detachment. This is especially relevant because PDS patients are often myopic, and myopia already increases retinal detachment risk.

51
New cards

How can laser peripheral iridotomy theoretically help pigmentary dispersion syndrome?

LPI may reduce iris concavity, decreasing posterior iris bowing and reducing iris-zonule friction that causes pigment liberation.

52
New cards

Which PDS patients may benefit most from LPI?

LPI may be most helpful in patients younger than 45 years with extreme peripheral iris concavity who are still actively liberating pigment.

53
New cards

Why does the potential benefit of LPI decrease after about age 45?

After age 45, many patients have already liberated much of their pigment, and age-related lens thickening naturally reduces iris-zonule friction. Therefore, LPI benefit likely diminishes.

54
New cards

How do pilocarpine and LPI both target the mechanism of PDS?

Both aim to reduce posterior iris concavity and decrease iris-zonule friction, reducing pigment release.

  • Pilocarpine: pharmacologically flattens iris via miosis

  • LPI: anatomically reduces iris concavity by altering pressure dynamics

55
New cards

What is pseudoexfoliation syndrome, and what gene is associated with it?

Pseudoexfoliation syndrome (PXF/PXE) is a systemic condition involving abnormal basement membranes and “elastosis,” associated with mutation in the LOXL1 gene.

56
New cards

What systemic diseases are associated with pseudoexfoliation syndrome?

PXF is associated with systemic vascular and neurodegenerative conditions, including:

  • Vascular insufficiency

  • TIAs

  • Heart attack

  • Stroke

  • Alzheimer’s disease

57
New cards

What are the key epidemiologic features of pseudoexfoliation syndrome?

PXF affects over 70 million people worldwide, is most common in Caucasians of Scandinavian descent, and is usually diagnosed between ages 60 and 80.

58
New cards

How important is pseudoexfoliation syndrome as a cause of open-angle glaucoma worldwide?

PXF causes about 20 to 25% of open-angle glaucoma worldwide, making it a major secondary glaucoma etiology.

59
New cards

What is the main ocular mechanism of pseudoexfoliation syndrome?

Weak abnormal basement membranes lead to loss/sloughing of epithelial cells, primarily from the iris and ciliary body, causing exfoliative material to accumulate in the anterior chamber.

60
New cards

Where is pseudoexfoliative material most classically observed in the eye?

Exfoliative cellular debris collects on nearby anterior segment tissues and is most classically seen on the anterior lens surface.

61
New cards

What are the classic zones of pseudoexfoliative material on the anterior lens capsule?

The classic pattern includes:

  • Central disc of material

  • Clear zone

  • Peripheral band of exfoliative material

<p>The classic pattern includes:</p><ul><li><p>Central disc of material</p></li><li><p>Clear zone</p></li><li><p>Peripheral band of exfoliative material</p></li></ul><p></p>
62
New cards

Why is pupillary dilation necessary when evaluating for pseudoexfoliation syndrome?

Dilation is needed to detect the classic bull’s-eye deposition pattern on the anterior lens surface, especially the peripheral exfoliative material.

63
New cards

What causes the clear zone in the pseudoexfoliation bull’s-eye pattern?

The clear zone forms because normal pupillary movement of the iris sweeps away exfoliative debris from that portion of the anterior lens surface.

64
New cards

What is the classic anterior lens appearance in pseudoexfoliation syndrome?

A bull’s-eye pattern on the anterior lens capsule, with a central disc, surrounding clear zone, and peripheral band of pseudoexfoliative material.

65
New cards

What pupil-margin finding is associated with pseudoexfoliation syndrome?

Pseudoexfoliative material can accumulate at the pupillary margin, appearing as flaky or dandruff-like material around the pupil.

<p>Pseudoexfoliative material can accumulate at the pupillary margin, appearing as flaky or dandruff-like material around the pupil.</p>
66
New cards

What iris transillumination defect pattern is associated with pseudoexfoliation syndrome?

PXF can cause peripupillary transillumination defects in a “moth-eaten” pattern.

67
New cards

How do iris transillumination defects differ between pigment dispersion syndrome and pseudoexfoliation syndrome?

  • PDS: radial midperipheral iris transillumination defects

  • PXF: peripupillary “moth-eaten” transillumination defects

<ul><li><p>PDS: radial midperipheral iris transillumination defects</p></li><li><p>PXF: peripupillary “moth-eaten” transillumination defects</p></li></ul><p></p>
68
New cards

How does pseudoexfoliation syndrome affect the zonules?

Exfoliative material can accumulate on the zonules, causing them to become frayed, weak, or broken.

69
New cards

What is the main mechanism of IOP elevation in pseudoexfoliation syndrome?

Fibrin-like, sticky pseudoexfoliative material clogs the trabecular meshwork outflow channels, increasing outflow resistance and raising IOP.

70
New cards

Besides trabecular outflow obstruction, what other outflow pathway is impaired in PXF?

Uveoscleral outflow is also impaired.

71
New cards

When does pseudoexfoliation syndrome become pseudoexfoliation glaucoma?

PXF becomes pseudoexfoliation glaucoma (PXG) when elevated IOP causes glaucomatous optic neuropathy.

72
New cards

What gonioscopic findings can be seen in pseudoexfoliation syndrome?

Gonioscopy may show excessive pigment in the angle and Sampolesi’s line.

73
New cards

How often do patients with pseudoexfoliation syndrome convert to glaucoma?

Patients with PXF may convert to glaucoma up to 60% of the time, with conversion reported more often in women than men.

74
New cards

How does pseudoexfoliation glaucoma compare with POAG at presentation?

Compared with POAG, PXG often presents with:

  • Higher IOP

  • Greater IOP fluctuations

  • Worse optic nerve head damage

  • Worse visual field damage at diagnosis

75
New cards

Why is pseudoexfoliation glaucoma considered more aggressive than POAG?

PXG tends to progress more rapidly after diagnosis, has greater IOP fluctuation, worse baseline ONH/VF damage, and a higher risk of treatment failure.

76
New cards

What is the treatment implication of pseudoexfoliation glaucoma being more aggressive than POAG?

The target IOP needs to be lower than in typical POAG because PXG has faster progression and greater risk of treatment failure.

77
New cards

Why does pseudoexfoliation glaucoma require more aggressive IOP management than typical POAG?

PXG has large IOP fluctuations, pressure spikes, and rapid visual field loss, so treatment usually requires a lower target IOP than typical POAG.

78
New cards

What is the recommended first-line medication class for pseudoexfoliation glaucoma?

Prostaglandin analogs (PGAs) are recommended first-line because PXG responds best to therapies that enhance outflow.

79
New cards

What role do ALT and SLT play in pseudoexfoliation glaucoma treatment?

ALT or SLT can be effective initial treatment options and may delay the need for medical therapy by up to 8 years, but success gradually declines over time.

80
New cards

What is a limitation of laser trabeculoplasty in PXG over time?

The IOP-lowering effect can wear off. After about 6 years, the effect wears off in roughly 50% of patients.

81
New cards

What general treatment strategy is preferred for medically treating pseudoexfoliation glaucoma?

Outflow enhancement is preferred because PXG involves impaired aqueous outflow from sticky fibrin-like pseudoexfoliative material clogging the trabecular meshwork.

82
New cards

When may pilocarpine be used in pseudoexfoliation glaucoma?

If PGA therapy fails, pilocarpine may be used, often dosed as 2% QHS, especially in older patients.

83
New cards

Why is pilocarpine often better tolerated in PXG than in pigmentary glaucoma?

PXG patients are typically older, so accommodative side effects are often less problematic than in young pre-presbyopic PDS patients. However, miosis can worsen vision in patients with dense nuclear sclerosis.

84
New cards

Why should pilocarpine and prostaglandin analogs theoretically not be used together?

Pilocarpine contracts the ciliary body muscle, limiting extracellular space between muscle fibers where PGAs act to increase uveoscleral outflow.

85
New cards

What are the possible outcomes if pilocarpine and PGAs are combined?

Results are variable:

  • IOP lowering may be additive

  • IOP may increase

  • The combination may have no additional effect

86
New cards

Why are some POAG treatments less effective in pseudoexfoliation glaucoma?

PXG has a different mechanism than POAG, with sticky fibrin-like material impairing outflow, so treatments effective in POAG may not produce the expected IOP reduction in PXG.

87
New cards

Why is cataract surgery not curative for pseudoexfoliation glaucoma?

Cataract surgery does not eliminate the underlying pseudoexfoliative process or reliably normalize IOP, so it is not curative for PXG.

88
New cards

Why is cataract surgery higher risk in patients with pseudoexfoliation syndrome?

PXF causes weak zonules, compromised capsules, and poor pupillary dilation, increasing surgical complication risk.

89
New cards

Why are aqueous suppressants not recommended as initial therapy for PXG?

Lowering aqueous production may reduce the pressure-driven movement of aqueous through the trabecular meshwork, causing aqueous to become more stagnant rather than clearing obstructive material.

90
New cards

What is the treatment contrasts between POAG and PXG?

  • POAG: aqueous suppressants and outflow enhancers can both be standard options

  • PXG: prioritize outflow enhancement with PGAs or laser because the main problem is impaired outflow from exfoliative material in the TM

91
New cards

What proportion of patients on topical steroids develop a clinically significant IOP rise?

About 3 to 30% of individuals treated with topical steroids develop an IOP increase of about 6 to 15 mmHg.

92
New cards

When does steroid-induced IOP elevation typically occur after starting topical steroids?

It typically occurs after at least 10 days of steroid use, but can appear anywhere from 1 to 4 weeks after initiation.

93
New cards

Who is at highest risk for steroid-induced glaucoma?

Risk is highest in:

  • Older adults

  • Patients with existing glaucoma

  • Patients with a family history of glaucoma

94
New cards

What is the main mechanism of steroid-induced glaucoma?

Steroids decrease aqueous outflow despite an open angle by altering the microstructure of the trabecular meshwork, increasing outflow resistance and raising IOP.

95
New cards

What genes are associated with steroid-induced glaucoma susceptibility?

Steroid-induced glaucoma is associated with alterations in MYOC, GLC1A, and/or TIGR genes.

96
New cards

What determines how much IOP rises with steroid use?

The IOP rise is proportional to the steroid’s:

  • Potency

  • Intraocular availability/penetration

97
New cards

Which topical steroids are more likely to cause larger IOP increases?

More potent and more penetrative steroids cause larger pressure rises. High-yield examples include:

  • Dexamethasone 0.1%: about 22 mmHg average rise

  • Durezol/difluprednate: about 17.8 mmHg rise

  • Prednisolone 1%: about 10 mmHg rise

98
New cards

What is the first step in treating steroid-induced glaucoma?

Stop or taper the topical steroid if clinically possible.

99
New cards

What should be done if a steroid responder still needs anti-inflammatory steroid treatment?

Consider switching to a less penetrative or lower-risk steroid, while monitoring IOP closely.

100
New cards

How should IOP be treated if steroid-induced pressure elevation persists?

Treat with topical beta-blockers or other aqueous suppressants until IOP normalizes.